China's Fosun Pharma Takes On Roche with Biosimilar Launch - swissinfo.ch

China's Fosun Pharma Takes On Roche with Biosimilar Launch  swissinfo.ch

(Bloomberg) -- After nearly two decades of dominance in treating lymphoma in China, Roche Holding AG is about to face direct competition from a Chinese ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases